{
    "2019-12-18": [
        [
            {
                "time": "2019-12-31",
                "original_text": "Top Dogs of the Dow Stocks to Own Heading Into 2020",
                "features": {
                    "keywords": [
                        "Dogs of the Dow",
                        "Stocks",
                        "Heading Into 2020"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-12-20",
                "original_text": "U.S. FDA Accepts and Grants Priority Review to sNDA for BRAFTOVI® (encorafenib) in Combination with ERBITUX® (cetuximab) (BRAFTOVI Doublet) for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer After Prior Therapy",
                "features": {
                    "keywords": [
                        "FDA",
                        "Priority Review",
                        "BRAFTOVI",
                        "ERBITUX",
                        "Metastatic Colorectal Cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-15",
                "original_text": "Pfizer and Mylan Announce Two Future Viatris Board Members",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Mylan",
                        "Viatris",
                        "Board Members"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-12-18",
                "original_text": "Lilly's Stock Up on Upbeat Sales & Profit Outlook for 2020",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Stock Up",
                        "Sales",
                        "Profit Outlook",
                        "2020"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}